US expert: Pfizer’s Corona vaccine will only work on every third person

On January 4, 2021, an article by the internationally recognized expert on the efficacy and safety of drugs, Assistant Professor Peter Doshi from Baltimore in the US, appeared in the respected British Medical Journal.

In this explosive article, which was deliberately overlooked by our “quality” media, Doshi not only analyzed the Pfizer study in the New England Journal of Medicine, but also several reports with a total of around 400 pages that Pfizer submitted to the US FDA on the Corona vaccine.

These documents show that not only the 170 test subjects who Pfizer evaluated in the study became ill, but also a further 3410 study participants, i.e. over 20 times more.

All suffered from symptoms of Covid-19 but were not included because the PCR tests they performed were negative. Of the total of 3 410 cases of suspected but unconfirmed Covid-19, 1 594 occurred in the vaccinated group and 1 816 in the placebo group of the unvaccinated.

Pharma expert Doshi commented: “With twenty times more suspected cases than confirmed cases, these suspected Covd-19 cases cannot simply be ignored simply because there was no positive PCR test result.”

After the possibility could not be ruled out that some of the suspected Covid 19 cases could be immediate vaccination reactions with Covid-like symptoms, Doshi picked out all suspected cases that had occurred within seven days.

After that, there were still 1 185 Covid-19 suspects among the vaccinated and 1529 among the unvaccinated. This results in an effectiveness of the vaccination of 29 percent.

There are also increasing reports of false negative PCR tests. Not only does the PCR test give a false positive but also false negative results.

In November, Professor Pietro Vernazza, Head of Infectious Diseases, reported on the experiences at the St. Gallen Cantonal Hospital: “In fact, in people who are hospitalized with suspected Covid-19, in 10 to 20 percent of cases in which all signs and findings are very typical of an infection, we cannot detect the pathogen using PCR in the nasopharynx swab. Evidence is often successful if the PCR test is then repeated in other swab materials (sputum, lung lavage fluid).”

A case in a Rosenheim hospital serves as a current example. An elderly woman died there from the typical clinical findings of Covid-19. However, two PCR tests performed were negative.

Pfizer obviously had not thought about possible false negative tests, and thus considered all 3 410 subjects who showed Covid 19 symptoms but had a negative PCR result as healthy, and excluded them from the evaluation.

The 3 410 “suspected Covid 19 cases” are only mentioned in the report by the powerful American drug agency FDA on the vaccine, because only this agency received the raw data for the study from Pfizer. Every pharmaceutical company in the world – including Pfizer – knows that it is better not to hide anything from the FDA.

The meager effectiveness of only 29 percent of the vaccine from Pfizer/Biontech calculated by Doshi could also explain why so many senior citizens have recently died in old people’s homes “despite the vaccination”. The narrative used by politics and the media that the vaccination came too late could soon become obsolete, because according to Doshi’s calculation, the conclusion is that the vaccination simply did not work for at least some of the later deceased.

If the 29 percent calculated by Doshi is even approximately correct, then the risk-benefit assessment of vaccination appears dim.

https://freewestmedia.com/2021/02/08/us-expert-pfizers-corona-vaccine-will-work-on-every-third-person/